Joint Formulary & PAD

Azathioprine - Respiratory disease indications

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Oral suspension
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Azathioprine
Indication :
Respiratory disease indications
Group Name :
Keywords :
RMOC, national shared care, Interstitial Lung Disease
Brand Names Include :
Imuran, Jayempi
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Drugs

Below are listed other drugs that are used to treat Respiratory disease indications.

Committee Recommendations (2)

Follow link to Shared Care Principles and Communication letters Shared Care principles and Communication letters

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for azathioprine and mercaptopurine for patients in adult services (non- transplant indications)